We are live on ! Find out more
OFM

Omega Fund Management Portfolio holdings

AUM $163M
1-Year Est. Return 107.06%
This Fund
S&P 500
This Quarter Est. Return
-9.67%
1 Year Est. Return
+107.06%
3 Year Est. Return
+111.75%
5 Year Est. Return
+84.24%
10 Year Est. Return
+495.59%
AUM
$198M
AUM Growth
-$33.2M
Cap. Flow
-$4.47M
Cap. Flow %
-2.26%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$2.51M
2
AKAO
Achaogen Inc
AKAO
+$1.95M

Sector Composition

Rank Sector Weight
1 Healthcare 60.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
$73.3M 37.02%
1,375,000
– –
PRTK
2
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$55.1M 27.83%
2,138,872
– –
EGLT
3
DELISTED
Egalet Corporation
EGLT
$38.2M 19.27%
2,645,558
– –
KYNB
4
Kyntra Bio
KYNB
$28.5M
$22.8M 11.54%
38,887
– –
TARA icon
5
Protara Therapeutics
TARA
$226M
$4.46M 2.25%
6,250
– –
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$3.12M 1.57%
223,457
-136,990
-38% -$2.51M
AKAO
7
DELISTED
Achaogen Inc
AKAO
$1M 0.51%
166,450
-315,244
-65% -$1.95M

Similar funds

HCCM
Hudson Canyon Capital Management New York $163M AUM 33.71% 1-Year Est. Return
PBO
Peoples Bank (Ohio) Marietta, Ohio $163M AUM 18.72% 1-Year Est. Return
PCR
Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
IVGAI
Index Venture Growth Associates IV St. Helier, Jersey $163M AUM 54.88% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return

Omega Fund Management's Q2 2015 Portfolio in Review

As of Q2 2015, Omega Fund Management held 7 positions worth $198M, down 14% from $231M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 0%. Omega Fund Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 58% a quarter earlier.

  • Omega Fund Management's biggest Q2 2015 reduction was Dicerna Pharmaceuticals, Inc., cutting an estimated $2.51M.
  • Omega Fund Management's ten largest holdings make up 100% of its $198M portfolio in Q2 2015.
  • Omega Fund Management opened 0 new positions and closed 0 in Q2 2015.
  • Omega Fund Management's portfolio value fell 14% quarter-over-quarter to $198M.

Based on Omega Fund Management's 13F filing for Q2 2015, filed 10 Aug 2015.